Report Detail
Global Endometriosis Treatment Drugs Market Growth 2019-2024
- RnM3154370 |
- 20 March, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Endometriosis affects a large number of women who are in their reproductive age. It is estimated to have a prevalence rate of 1 in 10 among women in the reproductive age group. The number is rising with the growing population count in that age range. Though there isn’t a complete cure for this condition, effective endometriosis treatment is provided through medication which suppresses the extreme pain suffered during endometriosis. There are many assumptions to be taken in order to estimate the correct prevalence of endometriosis patients. The absolute prevalent population is always limited as most cases in developing regions are not reported. Also, the awareness and understanding of different scales of pain is very limited in most regions. Hence, cases of endometriosis often get ignored. The situation persists in not only developing or poor socio-economic countries, but developed countries like the UK, where it is assumed that around 2 million women have undiagnosed endometriosis.
According to this study, over the next five years the Endometriosis Treatment Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Endometriosis Treatment Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Endometriosis Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Endometriosis Treatment Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Oral Type
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AbbVie Inc
Bayer AG
AstraZeneca
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Ipsen Pharma
Myovant Sciences Ltd
Endoceutics, Inc
Debiopharm Group
Mayne Pharma Group
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Endometriosis Treatment Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Endometriosis Treatment Drugs market by identifying its various subsegments.
Focuses on the key global Endometriosis Treatment Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Endometriosis Treatment Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Endometriosis Treatment Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Endometriosis Treatment Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Endometriosis Treatment Drugs Consumption 2014-2024
- 2.1.2 Endometriosis Treatment Drugs Consumption CAGR by Region
- 2.2 Endometriosis Treatment Drugs Segment by Type
- 2.2.1 Oral Type
- 2.2.2 Others
- 2.3 Endometriosis Treatment Drugs Consumption by Type
- 2.3.1 Global Endometriosis Treatment Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Endometriosis Treatment Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Endometriosis Treatment Drugs Sale Price by Type (2014-2019)
- 2.4 Endometriosis Treatment Drugs Segment by Application
- 2.4.1 Hospital Pharmacies
- 2.4.2 Retail Pharmacies
- 2.4.3 E-Commerce
- 2.4.4 Others
- 2.5 Endometriosis Treatment Drugs Consumption by Application
- 2.5.1 Global Endometriosis Treatment Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Endometriosis Treatment Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Endometriosis Treatment Drugs Sale Price by Application (2014-2019)
3 Global Endometriosis Treatment Drugs by Players
- 3.1 Global Endometriosis Treatment Drugs Sales Market Share by Players
- 3.1.1 Global Endometriosis Treatment Drugs Sales by Players (2017-2019)
- 3.1.2 Global Endometriosis Treatment Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Endometriosis Treatment Drugs Revenue Market Share by Players
- 3.2.1 Global Endometriosis Treatment Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Endometriosis Treatment Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Endometriosis Treatment Drugs Sale Price by Players
- 3.4 Global Endometriosis Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Endometriosis Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Endometriosis Treatment Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Endometriosis Treatment Drugs by Regions
- 4.1 Endometriosis Treatment Drugs by Regions
- 4.1.1 Global Endometriosis Treatment Drugs Consumption by Regions
- 4.1.2 Global Endometriosis Treatment Drugs Value by Regions
- 4.2 Americas Endometriosis Treatment Drugs Consumption Growth
- 4.3 APAC Endometriosis Treatment Drugs Consumption Growth
- 4.4 Europe Endometriosis Treatment Drugs Consumption Growth
- 4.5 Middle East & Africa Endometriosis Treatment Drugs Consumption Growth
5 Americas
- 5.1 Americas Endometriosis Treatment Drugs Consumption by Countries
- 5.1.1 Americas Endometriosis Treatment Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Endometriosis Treatment Drugs Value by Countries (2014-2019)
- 5.2 Americas Endometriosis Treatment Drugs Consumption by Type
- 5.3 Americas Endometriosis Treatment Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Endometriosis Treatment Drugs Consumption by Countries
- 6.1.1 APAC Endometriosis Treatment Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Endometriosis Treatment Drugs Value by Countries (2014-2019)
- 6.2 APAC Endometriosis Treatment Drugs Consumption by Type
- 6.3 APAC Endometriosis Treatment Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Endometriosis Treatment Drugs by Countries
- 7.1.1 Europe Endometriosis Treatment Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Endometriosis Treatment Drugs Value by Countries (2014-2019)
- 7.2 Europe Endometriosis Treatment Drugs Consumption by Type
- 7.3 Europe Endometriosis Treatment Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Endometriosis Treatment Drugs by Countries
- 8.1.1 Middle East & Africa Endometriosis Treatment Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Endometriosis Treatment Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Endometriosis Treatment Drugs Consumption by Type
- 8.3 Middle East & Africa Endometriosis Treatment Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Endometriosis Treatment Drugs Distributors
- 10.3 Endometriosis Treatment Drugs Customer
11 Global Endometriosis Treatment Drugs Market Forecast
- 11.1 Global Endometriosis Treatment Drugs Consumption Forecast (2019-2024)
- 11.2 Global Endometriosis Treatment Drugs Forecast by Regions
- 11.2.1 Global Endometriosis Treatment Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Endometriosis Treatment Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Endometriosis Treatment Drugs Forecast by Type
- 11.8 Global Endometriosis Treatment Drugs Forecast by Application
12 Key Players Analysis
- 12.1 AbbVie Inc
- 12.1.1 Company Details
- 12.1.2 Endometriosis Treatment Drugs Product Offered
- 12.1.3 AbbVie Inc Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 AbbVie Inc News
- 12.2 Bayer AG
- 12.2.1 Company Details
- 12.2.2 Endometriosis Treatment Drugs Product Offered
- 12.2.3 Bayer AG Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Bayer AG News
- 12.3 AstraZeneca
- 12.3.1 Company Details
- 12.3.2 Endometriosis Treatment Drugs Product Offered
- 12.3.3 AstraZeneca Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 AstraZeneca News
- 12.4 Pfizer Inc
- 12.4.1 Company Details
- 12.4.2 Endometriosis Treatment Drugs Product Offered
- 12.4.3 Pfizer Inc Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Pfizer Inc News
- 12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Company Details
- 12.5.2 Endometriosis Treatment Drugs Product Offered
- 12.5.3 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Teva Pharmaceutical Industries Ltd News
- 12.6 Ipsen Pharma
- 12.6.1 Company Details
- 12.6.2 Endometriosis Treatment Drugs Product Offered
- 12.6.3 Ipsen Pharma Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Ipsen Pharma News
- 12.7 Myovant Sciences Ltd
- 12.7.1 Company Details
- 12.7.2 Endometriosis Treatment Drugs Product Offered
- 12.7.3 Myovant Sciences Ltd Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Myovant Sciences Ltd News
- 12.8 Endoceutics, Inc
- 12.8.1 Company Details
- 12.8.2 Endometriosis Treatment Drugs Product Offered
- 12.8.3 Endoceutics, Inc Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Endoceutics, Inc News
- 12.9 Debiopharm Group
- 12.9.1 Company Details
- 12.9.2 Endometriosis Treatment Drugs Product Offered
- 12.9.3 Debiopharm Group Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Debiopharm Group News
- 12.10 Mayne Pharma Group
- 12.10.1 Company Details
- 12.10.2 Endometriosis Treatment Drugs Product Offered
- 12.10.3 Mayne Pharma Group Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Mayne Pharma Group News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Endometriosis Treatment Drugs . Industry analysis & Market Report on Endometriosis Treatment Drugs is a syndicated market report, published as Global Endometriosis Treatment Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Endometriosis Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
